Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Operating Leases (2019 - 2025)

INVO Fertility has reported Operating Leases over the past 7 years, most recently at $2.0 million for Q3 2025.

  • Quarterly Operating Leases fell 11.8% to $2.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2025, down 11.8% year-over-year, with the annual reading at $2.2 million for FY2024, 34.76% down from the prior year.
  • Operating Leases was $2.0 million for Q3 2025 at INVO Fertility, down from $2.1 million in the prior quarter.
  • Over five years, Operating Leases peaked at $3.4 million in Q3 2023 and troughed at -$305866.0 in Q1 2023.
  • The 5-year median for Operating Leases is $2.0 million (2025), against an average of $1.7 million.
  • Year-over-year, Operating Leases soared 2683.59% in 2022 and then plummeted 120.82% in 2023.
  • A 5-year view of Operating Leases shows it stood at $1.5 million in 2021, then decreased by 10.62% to $1.3 million in 2022, then surged by 149.08% to $3.4 million in 2023, then crashed by 34.76% to $2.2 million in 2024, then decreased by 9.25% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Operating Leases are $2.0 million (Q3 2025), $2.1 million (Q2 2025), and $2.1 million (Q1 2025).